27 Feb, EOD - Indian

Nifty IT 30603.85 (0.16)

SENSEX 81287.19 (-1.17)

Nifty 50 25178.65 (-1.25)

Nifty Pharma 22952.35 (-1.50)

Nifty Midcap 100 59115.6 (-1.14)

Nifty Bank 60529 (-1.08)

Nifty Next 50 69710.9 (-1.30)

Nifty Smallcap 100 16928.9 (-1.10)

27 Feb, EOD - Global

NIKKEI 225 58850.27 (0.16)

HANG SENG 26630.54 (0.95)

S&P 6891.85 (-0.55)


Mid Session News

You are Here : Home > News > Mid Session News >

(26 Feb 2026, 12:34)

Barometers pare gains; media shares decline


The key equity benchmarks reversed all gains and traded with minor losses in early afternoon trade. The Nifty traded below the 25,450 mark. Media shares declined after advancing for previous trading session.

At 12:30 IST, the barometer index, the S&P BSE Sensex, declined 181.44 points or 0.22% to 82,094.63. The Nifty 50 index fell 54.05 points or 0.21% to 25,428.45.

The broader market underperformed the frontline indices. The BSE 150 MidCap Index fell 0.01% and the BSE 250 SmallCap Index fell 0.18%.

The market breadth was negative. On the BSE, 1,949 shares rose and 1,972 shares fell. A total of 202 shares were unchanged.

Derivatives:

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, slumped 8.05% to 13.01. The Nifty 30 March 2026 futures were trading at 25,608.90, at a premium of 1 points as compared with the spot at 25,428.45.

The Nifty option chain for the 30 March 2026 expiry showed a maximum call OI of 57.7 lakh contracts at the 26,000 strike price. Maximum put OI of 66.1 lakh contracts was seen at 25,000 strike price.

Buzzing Index:

The Nifty Media index fell 0.78% to 1,406.35. The index added 0.46% in the past trading session.

Prime Focus (down 1.41%), D B Corp (down 1.33%), Tips Music (down 1.19%), Saregama India (down 1.07%) and Zee Entertainment Enterprises (down 1.06%), PVR Inox (down 1%), Network 18 Media & Investments (down 0.44%), Sun TV Network (down 0.34%) fell.

Stocks in Spotlight:

Capacite Infraprojects fell 1.62%. The company said that it has received a letter of intent (LOI) from TenX Realty (on behalf of Raymond) for a total contract value of approximately Rs 537 crore.

Alembic Pharmaceuticals fell 1.15%. The company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Lamotrigine Orally Disintegrating Tablets USP, 25 mg, 50 mg, 100 mg, and 200 mg.

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +